Aggressiveness of Cancer Care Near the End of Life: Is It a Quality-of-Care Issue?
Brigham and Women's Hospital · Harvard University · +2 more institutions
Abstract
The purpose of this article is to review the literature and update analyses pertaining to the aggressiveness of cancer care near the end of life. Specifically, we will discuss trends and factors responsible for chemotherapy overuse very near death and underutilization of hospice services. Whether the concept of overly aggressive treatment represents a quality-of-care issue that is acceptable to all involved stakeholders is an open question.
Citation impact
- FWCI
- 24.41
- Percentile
- 100%
- References
- 40
Authors
6- CCCraig C. EarleCorresponding
Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center
- MBMary Beth Landrum
Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center
- JMJeffrey M. Souza
Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center
- BABridget A. Neville
Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center
- JCJane C. Weeks
Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center
Topics & keywords
- Medicine
- End-of-life care
- Cancer
- Quality of life (healthcare)
- Quality (philosophy)
- Intensive care medicine
- Nursing
- Palliative care